Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome  Nadine Schuler, Jan Palm, Sabine Schmitz, Yvonne Lorat, Claudia.

Slides:



Advertisements
Similar presentations
Volume 314, Issue 1, Pages (January 2012)
Advertisements

Decline of Tumor Vascular Function as Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is Associated With Poor Responses to Radiation.
In Vitro and In Vivo Studies of Non-Platinum-Based Halogenated Compounds as Potent Antitumor Agents for Natural Targeted Chemotherapy of Cancers  Qing-Bin.
Conclusions THE ROLE OF APOPTOSIS IN PITUITARY
Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans  Christian Rønn Hansen, Anders Bertelsen, Irene Hazell,
Physics and Imaging in Radiation Oncology
High-Throughput Multi-parametric Imaging Flow Cytometry
Volume 7, Issue 6, Pages (December 2016)
Sperm macrocephaly syndrome in a patient without AURKC mutations and with a history of recurrent miscarriage  Emanuela Molinari, Marzia Mirabelli, Stefania.
The impact of the IGF-1 system of cancer cells on radiation response – An in vitro study  Senthiladipan Venkatachalam, Esther Mettler, Christian Fottner,
MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis  Motofumi.
Volume 5, Issue 3, Pages (September 2015)
Evaluation of diffusion weighted imaging for tumor delineation in head-and-neck radiotherapy by comparison with automatically segmented 18F-fluorodeoxyglucose.
European Urology Oncology
2-[18F]fluoro-2-deoxy-d-galactose positron emission tomography guided functional treatment planning of stereotactic body radiotherapy of liver tumours 
Jacob Andrade, Shundi Ge, Goar Symbatyan, Michael S. Rosol, Arthur J
Decreased expression of Wiskott–Aldrich syndrome protein family verprolin-homologous protein 2 may be involved in the development of pre-eclampsia  Juan.
3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis  Perla Pérez-Treviño, Héctor Hernández-De.
Ret mouse very large tumors (VLTs) display altered ratios of infiltrating memory to naive T cells: Roles in tumor expansion  Mohammad W. Khan, Viktor.
The Zinc Ionophore PCI-5002 Radiosensitizes Non-small Cell Lung Cancer Cells by Enhancing Autophagic Cell Death  Kwang Woon Kim, PhD, Christina K. Speirs,
2-[18F]fluoro-2-deoxy-d-galactose positron emission tomography guided functional treatment planning of stereotactic body radiotherapy of liver tumours 
Automatic treatment planning improves the clinical quality of head and neck cancer treatment plans  Christian Rønn Hansen, Anders Bertelsen, Irene Hazell,
Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy  Nicola S. Russell, Inge.
Radiotherapy dose-distribution to the perirectal fat space (PRS) is related to gastrointestinal control-related complications  S.L. Gulliford, S. Ghose,
Do protons and X-rays induce cell-killing in human peripheral blood lymphocytes by different mechanisms?  J. Miszczyk, K. Rawojć, A. Panek, A. Borkowska,
Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma  André Lechel, Michael P. Manns, K.Lenhard Rudolph 
S. Ginart, M. Caputo, D. Corach, A. Sala 
Jacob Andrade, Shundi Ge, Goar Symbatyan, Michael S. Rosol, Arthur J
Physics and Imaging in Radiation Oncology
Physics and Imaging in Radiation Oncology
Valentina Manfé, Edyta Biskup, Peter Johansen, Maria R
Caspase-3 Promotes Genetic Instability and Carcinogenesis
Carola Hartel, Elena Nasonova, Martina C. Fuss, Anna V
VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: The incidental effect of low-dose bath exposure  G. Lazzari, A. Terlizzi,
Resolution of atelectasis during radiochemotherapy of lung cancer with serious implications for further treatment. A case report  Lore Helene Braun, Stefan.
Physics and Imaging in Radiation Oncology
Differential expression of functional chemokine receptors on human blood and lung group 2 innate lymphoid cells  Cathryn A. Weston, PhD, Batika M.J. Rana,
Axillary radiotherapy for nodal lymphoma: What CTV expansion is required to account for absence of pre-chemotherapy treatment position FDG PET-CT?  Robin.
Physics and Imaging in Radiation Oncology
Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapy  Sara Leibfarth, René M. Winter, Heidi Lyng, Daniel Zips, Daniela.
Measurements of metastatic renal cell tumours as determined by diffusion weighted imaging or computed tomography are in close agreement, a pilot study 
Advantages of intensity modulated proton therapy during hippocampal avoidance whole brain radiation therapy  Joshua Stoker, Sujay Vora, Ameet Patel, David.
Volume 4, Issue 1, Pages (January 2015)
Simultaneous integrated prophylactic cranial irradiation in sino-nasal cancer  Kenneth Jensen, Maja Bendtsen Sharma, Simon Lenler-Eriksen, Per Friis, Anne.
Franziska Hauth, Mahmoud Toulany, Daniel Zips, Apostolos Menegakis 
Characterizing geometrical accuracy in clinically optimised 7T and 3T magnetic resonance images for high-precision radiation treatment of brain tumours 
Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer  Katrina Woodford, Vanessa Panettieri, Trieumy Tran Le,
Volume 3, Issue 4, Pages (October 2014)
Technical Innovations and Patient Support in Radiation Oncology
Raymond L. Warters, Patrick J. Adamson, Christopher D. Pond, Sancy A
Physics and Imaging in Radiation Oncology
Masayuki Yamashita, Eriko Nitta, Toshio Suda  Cell Stem Cell 
Volume 3, Issue 5, Pages (May 2013)
Ret mouse very large tumors (VLTs) display altered ratios of infiltrating memory to naive T cells: Roles in tumor expansion  Mohammad W. Khan, Viktor.
Uncertainty evaluation of image-based tumour control probability models in radiotherapy of prostate cancer using a visual analytic tool  Oscar Casares-Magaz,
The posterior cerebellum, a new organ at risk?
Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer 
Cone beam CT based dose calculation in the thorax region
Volume 41, Issue 5, Pages (November 2004)
Volume 19, Issue 9, Pages (May 2017)
Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer  Shyama U. Tetar, Anna M.E. Bruynzeel,
Technical Innovations and Patient Support in Radiation Oncology
Peter de Boer, Stefano Mandija, Anita M
Clinical and Translational Radiation Oncology
The rationale for MR-only treatment planning for external radiotherapy
Surface doses of flattening filter free beams with volumetric modulated arc therapy dose delivery for breast cancer  Jan Seppälä, Aleksi Voutilainen,
R. Botman, S. U. Tetar, M. A. Palacios, B. J. Slotman, F. J
Volume 7, Issue 6, Pages (December 2016)
Physics and Imaging in Radiation Oncology
Volumetric and dosimetric comparison of two delineation guidelines for the radiation treatment of laryngeal squamous cell carcinoma  C. Bondue, S. Racadot,
Presentation transcript:

Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome  Nadine Schuler, Jan Palm, Sabine Schmitz, Yvonne Lorat, Claudia E. Rübe  Clinical and Translational Radiation Oncology  Volume 7, Pages 71-78 (December 2017) DOI: 10.1016/j.ctro.2017.10.004 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Tumor therapy of the LFS patient. A: Evaluation of the treatment response by magnetic resonance tomography (MRT): T1-weighted images acquired in axial plane reveals the choroid plexus carcinoma (CPC) with enlargement of the ventricle before and after tumour resection and adjuvant radio-/chemotherapy. B: Craniospinal irradiation includes large volumes of active bone marrow. Colour-wash presentation illustrates the dose distribution. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Clinical and Translational Radiation Oncology 2017 7, 71-78DOI: (10.1016/j.ctro.2017.10.004) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 53BP1-foci as a marker for radiation-induced DNA damage. A: Immunohistochemical staining of 53BP1 in blood lymphocytes of a healthy individual analyzed 0.5, 8, and 24 h after ex-vivo irradiation with 2 Gy, compared to non-irradiated control. B: DNA repair capacity: 53BP1-foci were measured in blood lymphocytes from LFS patient (p53-mut), healthy TP53 carriers (p53-mut), and healthy individuals (p53-wt) and tumor-patient (p53-wt) at defined time-points after ex-vivo irradiation with 2 Gy. Inset shows 53BP1-foci levels in non-irradiated blood lymphocytes. C: Gradual accumulation of persisting 53BP1-foci during craniospinal irradiation (in vivo) of LFS patient (p53-mut), compared to the tumor-patient (p53-wt). 53BP1 foci were quantified 0.5 h (induction) and 24 h after the first fraction (1×), 24 h after 5×, 10×, 15× and 20× fractions (1.8 Gy), as well as 1, 2, 3 and 4 months after completion of RT. 53BP1-foci levels in the tumor-patient (p53-wt) did not increase during craniospinal irradiation (horizontal lines). Clinical and Translational Radiation Oncology 2017 7, 71-78DOI: (10.1016/j.ctro.2017.10.004) Copyright © 2017 The Authors Terms and Conditions

Fig. 3 Radiation-induced cell cycle arrest and apoptosis analysed by flow cytometry Blood lymphocytes from the LFS patient were analyzed before and after ex-vivo irradiation with 2 Gy, compared to healthy individuals. A: Cell cycle distribution determined with propidium iodide DNA staining: Analysis gates were set on forward versus side scatter to exclude debris and cell aggregates and to delineate subG1 (purple), G0/G1 (green) and S/G2 population (blue) (upper panel). B: Induction of Caspase3-dependent apoptosis: Median fluorescence intensity was measured in lymphocytes from LFS patient before and after ex-vivo irradiation with 2 Gy, compared to healthy individuals. In contrast to the LFS patient, healthy lymphocytes in G0/G1 and S/G2 phase show high Caspase3 intensity, particularly after irradiation (red line, left panel). Data from 3 different experiments are presented as mean ± standard equivalent. *Significantly different compared with non-irradiated control (p ≥ 0.05). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Clinical and Translational Radiation Oncology 2017 7, 71-78DOI: (10.1016/j.ctro.2017.10.004) Copyright © 2017 The Authors Terms and Conditions

Fig. 4 Ultrastructural characterization of DNA lesions and chromosome analysis. Analyzed blood lymphocytes from the LFS patient were obtained 1 month after RT. A: TEM overview micrograph of peripheral blood lymphocytes. B: TEM micrographs of double-labeling of pKu70 (10-nm beads, red) and p53BP1 (6-nm beads, green) at different magnifications (boxed regions are shown at higher magnifications in the following images). Co-localization of pKu70 and 53BP1 in electron-dense regions, reflecting actively processed DSBs in heterochromatin. C: SEM micrograph of metaphase chromosomes of LFS patient reveals structural chromosome aberrations. D: mFISH Karyogram of the LFS patient (1 month after RT) shows multiple structural and numerical aberrations and can be described as follows: 49,XY,t(1;6;17),t(1;12),t(1;12),ace2,−3,t(4;16),t(4;16),+5,+5,del(6),del(6),+7,+7,t(6;7),t(6;7),−8,9,+11,t(12;1),t(12;1),add(13),t(13;X),−14,t(14;16),+15,del(16),del(16),+17,+18,+19−21. E: mFISH Karyogram of a healthy female individual. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) Clinical and Translational Radiation Oncology 2017 7, 71-78DOI: (10.1016/j.ctro.2017.10.004) Copyright © 2017 The Authors Terms and Conditions

Supplemental 1 Detection of persisting small 53BP1-foci in blood lymphocytes after craniospinal irradiation of the LFS patient. A: Immunohistochemical double-staining of 53BP1 and γH2AX in blood lymphocytes of LFS patient analyzed 1 month after craniospinal irradiation. B: Quantification of 53BP1 foci per cell and 53BP1-positive cells 1, 2, 3 and 4 months after completion of craniospinal irradiation. Clinical and Translational Radiation Oncology 2017 7, 71-78DOI: (10.1016/j.ctro.2017.10.004) Copyright © 2017 The Authors Terms and Conditions